Identification of a potential target for treatment of squamous cell carcinoma of the tongue: follistatin

Identification of a potential target for treatment of squamous cell carcinoma of the tongue: follistatin: Squamous cell carcinoma (SCC) of the tongue is the most common oral cancer. Because of the tongue’s frequent movement, abundant lymphatic drainage, and rich blood supply, the SCC is prone to regional lymph nodes and distant metastases, and its prognosis is worse than that of the other oral cancers.1 In addition, because of its special location, it and its secondary tissue defect postperatively may impair the patient’s pronunciation and swallowing. Reliable and stable therapeutic targets can improve the curative effect and reduce the toxic side effects caused by surgery, radiotherapy, and chemotherapy.